| Miss Patricia Ann Sheets, LPN | |
|
316 N. Terrace St., Janbesville, WI 53548 | |
| (608) 314-4558 | |
| Not Available |
| Full Name | Miss Patricia Ann Sheets |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 316 N. Terrace St., Janbesville, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578846010 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 32503 (Wisconsin) | Primary |
| 3747A0650X | Technician - Attendant Care Provider | 32503 (Wisconsin) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Patricia Ann Sheets, LPN 316 N. Terrace St, Janesville, WI 53548 Ph: (608) 314-4558 | Miss Patricia Ann Sheets, LPN 316 N. Terrace St., Janbesville, WI 53548 Ph: (608) 314-4558 |
News Archive
Naturally-derived anti-oxidants have become the 'it' health ingredient to look for in food. But researchers from UBC Okanagan and the University of Bologna have discovered that TEMPO-a well-known artificial anti-oxidant-is up to 100 times more powerful than nature's best and could help counteract everything from skin damage to Alzheimer's Disease.
Ligand Pharmaceuticals Incorporated announced that it has completed the acquisition of Metabasis Therapeutics, Inc. (NASDAQ:MBRX), following approval of the transaction by Metabasis stockholders yesterday. As a result, Ligand gains a fully funded partnership with Roche, additional pipeline assets and drug discovery technologies and resources. The transaction was first announced on October 27, 2009.
A new clinical trial offers the most compelling evidence to date that a donor stem cell transplant can improve survival rates for older patients with higher-risk myelodysplastic syndrome (MDS), Dana-Farber Cancer Institute investigators report at the virtual 62nd American Society of Hematology Annual Meeting.
Scientists from Nanyang Technological University have successfully used dead bacteria to kill colorectal cancer cells. Harvesting the Clostridium sporogenes bacteria found commonly in soil, the NTU team was able to harness the bacteria in its dead form, and its secretions, to destroy colon tumours cells effectively.
Prospects for inhibiting the most dangerous symptoms of allergic reactions may be brighter with the publication of a new study that identifies a possible target for drug therapies.
› Verified 8 days ago